Reproductive screening for fragile X syndrome, spinal muscular atrophy and cystic fibrosis recommended for funding by MSAC
20 October, 2020

Following an application by the Royal College of Pathologists of Australasia (RCPA), the Medical Services Advisory Committee (MSAC) has recommended to the Health Minister, Greg Hunt, that reproductive carrier screening for fragile X syndrome (FXS), spinal muscular atrophy (SMA) and cystic fibrosis (CF) be listed on the Medicare Benefits Schedule (MBS).

Go Back

Page last updated:

Copyright © 2020 RCPA. All rights reserved.

21-Oct-2020
Top